A routine eye exam can reveal early signs of various health conditions, including diabetes, high blood pressure, and even autoimmune diseases.

Study insights could improve current understanding of neurodegenerative diseases as well as interpretations of brain scans.

Boehringer Ingelheim announces the start of the THULITE Phase II clinical study. It will investigate the efficacy, safety and tolerability of BI 1815368 as a potential oral treatment to improve vision ...